Moberg Pharma Acquires OTC Brands from Bayer

Moberg Pharma AB, a Swedish pharmaceutical company,  has signed a deal to acquire three over-the-coutner brands in the US from Bayer HealthCare. The acquired portfolio includes: Domeboro, a topical astringent used for relieving itch and minor skin irritations; Vanquish, an internal analgesic; and Fergon, an iron supplement. The brands will be sold through Moberg’s current channel, primarily in chain drugstores and mass retailers, such as Walmart. The transaction is expected to close before the end of 2013.

Source: Moberg Pharma